title: Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.
abstract: Peritoneal carcinomatosis in gastric cancer is associated with a dismal prognosis. Systemic chemotherapy is not effective because of the existence of a blood-peritoneal barrier. Cytoreductive surgery and intraperitoneal chemotherapy can improve survival and quality of life in selected patients. Patient selection for this multimodal approach is one of the most critical issues, and calls for interdisciplinary evaluation by radiologists, medical and surgical oncologists, and anaesthetists. This article sets forth criteria for selection of gastric cancer patients suffering from peritoneal carcinomatosis.
authors.affiliation: Department of General, Visceral and Transplant Surgery, Tübingen University Hospital, 72076 Tübingen, Germany. ingmar.koenigsrainer@med.uni-tuebingen.de
authors.forename: Ingmar
authors.initials: I
authors.lastname: Königsrainer
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002277:Carcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D003131:Combined Modality Therapy; D006801:Humans; D006979:Hyperthermia, Induced; D010535:Laparoscopy; D018579:Patient Selection; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D013274:Stomach Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*
chemical_list: D000970:Antineoplastic Agents
references.citation: CA Cancer J Clin. 1999 Jan-Feb;49(1):33-64, 1
references.pmid: 10200776
references.citation: Int J Cancer. 2010 Mar 15;126(6):1513-20
references.pmid: 19688824
references.citation: Cell Physiol Biochem. 2008;21(5-6):429-36
references.pmid: 18453750
references.citation: Cancer Treat Res. 1996;82:359-74
references.pmid: 8849962
references.citation: Surg Oncol Clin N Am. 2003 Jul;12(3):635-48
references.pmid: 14567022
references.citation: Cancer. 1999 Feb 1;85(3):529-34
references.pmid: 10091726
references.citation: J Clin Epidemiol. 2003 Jan;56(1):1-9
references.pmid: 12589864
references.citation: Cancer Treat Res. 2007;134:357-73
references.pmid: 17633066
references.citation: Cell Physiol Biochem. 2010;26(2):147-54
references.pmid: 20798498
references.citation: Eur J Surg Oncol. 2008 Feb;34(2):154-8
references.pmid: 17640844
references.citation: Ann Surg Oncol. 2009 Feb;16(2):327-33
references.pmid: 19050972
references.citation: Gastric Cancer. 2001;4(1):27-33
references.pmid: 11706624
references.citation: Eur J Surg Oncol. 2006 Aug;32(6):625-7
references.pmid: 16822641
references.citation: Ann Surg Oncol. 2007 Oct;14(10):2702-13
references.pmid: 17653801
references.citation: World J Gastrointest Oncol. 2010 Feb 15;2(2):85-97
references.pmid: 21160926
references.citation: Ann Surg Oncol. 2009 May;16(5):1295-303
references.pmid: 19252950
references.citation: J Surg Oncol. 2009 Sep 15;100(4):311-6
references.pmid: 19697437
references.citation: J Clin Oncol. 2006 Nov 1;24(31):4991-7
references.pmid: 17075117
references.citation: Ann Surg Oncol. 2007 Jan;14(1):128-33
references.pmid: 17072675